TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scienta Omicron AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
13,488
|
9,011
|
6,362 |
| Financial expenses |
150
|
811
|
380 |
| Earnings before taxes |
2,525
|
-168
|
-1,117 |
| EBITDA |
3,062
|
869
|
-650 |
| Total assets |
6,165
|
5,717
|
8,521 |
| Current assets |
5,073
|
4,598
|
7,605 |
| Current liabilities |
4,761
|
5,052
|
7,601 |
| Equity capital |
1,230
|
394
|
560 |
| - share capital |
37
|
38
|
38 |
| Employees (average) |
31
|
25
|
25 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.0%
|
6.9%
|
6.6% |
| Turnover per employee |
435
|
360
|
254 |
| Profit as a percentage of turnover |
18.7%
|
-1.9%
|
-17.6% |
| Return on assets (ROA) |
43.4%
|
11.2%
|
-8.6% |
| Current ratio |
106.6%
|
91.0%
|
100.1% |
| Return on equity (ROE) |
205.3%
|
-42.6%
|
-199.5% |
| Change turnover |
4,784
|
2,631
|
-764 |
| Change turnover % |
55%
|
41%
|
-11% |
| Chg. No. of employees |
6
|
0
|
-5 |
| Chg. No. of employees % |
24%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.